HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ling Xie Selected Research

Ligands

1/2022TF-DUBTACs Stabilize Tumor Suppressor Transcription Factors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ling Xie Research Topics

Disease

27Neoplasms (Cancer)
01/2022 - 01/2003
10Inflammation (Inflammations)
01/2022 - 03/2013
8Spinal Cord Injuries (Spinal Cord Injury)
01/2022 - 01/2018
8Breast Neoplasms (Breast Cancer)
01/2021 - 01/2013
6Carcinogenesis
01/2022 - 02/2002
5Lung Neoplasms (Lung Cancer)
01/2020 - 02/2002
4Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
06/2022 - 01/2018
4Neoplasm Metastasis (Metastasis)
11/2021 - 05/2003
4Mitochondrial Diseases (Mitochondrial Disease)
01/2021 - 01/2019
4Traumatic Brain Injuries (Traumatic Brain Injury)
01/2020 - 09/2017
3Critical Illness (Critically Ill)
08/2022 - 08/2017
3Triple Negative Breast Neoplasms
07/2022 - 11/2019
3Stomach Neoplasms (Stomach Cancer)
01/2022 - 01/2018
3COVID-19
08/2021 - 08/2020
3Hypoxia (Hypoxemia)
01/2020 - 04/2014
3Alzheimer Disease (Alzheimer's Disease)
01/2019 - 05/2002
3Carcinoma (Carcinomatosis)
08/2012 - 07/2011
2Heart Failure
01/2022 - 01/2018
2Fibrosis (Cirrhosis)
01/2022 - 12/2018
2Demyelinating Diseases (Demyelinating Disease)
10/2021 - 01/2021
2Acute Coronary Syndrome
02/2021 - 01/2021
2Atherosclerosis
01/2021 - 01/2018
2Pain (Aches)
01/2021 - 01/2019
2Colorectal Neoplasms (Colorectal Cancer)
08/2020 - 10/2012
2Albuminuria
01/2020 - 01/2019
2Renal Cell Carcinoma (Grawitz Tumor)
10/2019 - 01/2018
2Pancreatitis
01/2019 - 01/2018
2Diabetic Nephropathies (Diabetic Nephropathy)
12/2018 - 11/2015
2Infections
08/2017 - 08/2014
2Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
10/2015 - 10/2011
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2013 - 11/2005
2Esophageal Squamous Cell Carcinoma
08/2012 - 07/2011
1Stroke (Strokes)
08/2022
1Dry Eye Syndromes (Dry Eye Syndrome)
05/2022
1Neuralgia (Stump Neuralgia)
05/2022
1Autoimmune Diseases (Autoimmune Disease)
01/2022
1Atrial Fibrillation
01/2022
1Neuroinflammatory Diseases
01/2022
1Multiple Sclerosis
12/2021
1Immune System Diseases (Immune Disorders)
10/2021

Drug/Important Bio-Agent (IBA)

19Proteins (Proteins, Gene)FDA Link
08/2022 - 01/2003
7Biomarkers (Surrogate Marker)IBA
01/2021 - 01/2018
6Messenger RNA (mRNA)IBA
01/2021 - 02/2002
6Peptides (Polypeptides)IBA
01/2019 - 05/2002
5CytokinesIBA
01/2020 - 01/2018
5ProteomeIBA
01/2017 - 01/2003
4Transcription Factors (Transcription Factor)IBA
01/2022 - 01/2018
4DNA (Deoxyribonucleic Acid)IBA
08/2020 - 10/2012
4isoliquiritigenin (GU 17)IBA
01/2019 - 01/2018
3CateninsIBA
01/2022 - 10/2018
3MicroRNAs (MicroRNA)IBA
10/2021 - 05/2014
3Biological ProductsIBA
01/2021 - 07/2011
3EndotoxinsIBA
11/2020 - 03/2013
3Pharmaceutical PreparationsIBA
08/2020 - 01/2018
3ErbB Receptors (EGF Receptor)IBA
01/2020 - 11/2005
3IronIBA
12/2018 - 08/2012
2Proteolysis Targeting ChimeraIBA
07/2022 - 01/2020
2SolutionsIBA
05/2022 - 01/2020
2artemisinin (artemisinine)IBA
01/2022 - 10/2021
2Carrier Proteins (Binding Protein)IBA
11/2021 - 06/2012
2Membrane Proteins (Integral Membrane Proteins)IBA
11/2021 - 11/2012
2LipidsIBA
01/2021 - 01/2018
2Fibroblast Growth Factor 1 (FGF-1)IBA
01/2021 - 12/2018
2Freund's AdjuvantIBA
01/2021 - 01/2019
2Streptozocin (Streptozotocin)FDA Link
01/2021 - 11/2015
2Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
01/2020 - 01/2018
2Nerve Growth Factor (NGF)IBA
01/2020 - 01/2020
2Small Interfering RNA (siRNA)IBA
01/2020 - 07/2011
2oxalylglycineIBA
01/2020 - 12/2019
2Neuroprotective AgentsIBA
01/2020 - 05/2012
2EnzymesIBA
11/2019 - 05/2019
2ChromatinIBA
07/2019 - 03/2013
2Therapeutic UsesIBA
10/2017 - 11/2015
2Phenobarbital (Luminal)FDA Link
03/2016 - 02/2016
2Methylphenidate (Ritalin)FDA LinkGeneric
10/2015 - 10/2011
2SERPIN-B5 (maspin)IBA
05/2003 - 01/2003
1Enhancer of Zeste Homolog 2 ProteinIBA
07/2022
1Polycomb Repressive Complex 2IBA
07/2022
1methyl butyrateIBA
06/2022
1Purinergic P2X3 ReceptorsIBA
05/2022
1Scopolamine (Hyoscine)FDA Link
05/2022
1Protein Kinase CIBA
05/2022
1sesamolIBA
01/2022
1Deubiquitinating EnzymesIBA
01/2022
1LigandsIBA
01/2022
1Laminin (Merosin)IBA
01/2022
1OligonucleotidesIBA
01/2022
1A-Form DNA (A-DNA)IBA
01/2022
1TPN10466IBA
01/2022
1Sirtuin 1IBA
01/2022
1Aurora Kinase BIBA
12/2021
1methyl acetateIBA
12/2021
1SolventsIBA
12/2021
1Acetates (Acetic Acid Esters)FDA Link
12/2021
1CalciumIBA
11/2021
1IntegrinsIBA
11/2021

Therapy/Procedure

14Therapeutics
12/2021 - 11/2005
4Drug Therapy (Chemotherapy)
01/2018 - 03/2003
1Subcutaneous Injections
05/2022
1Electroacupuncture
05/2022